Brief: Selecta Biosciences Reports Fourth Quarter And Full Year 2022 Financial Results

Cartesian Therapeutics

02/03/2023 12:41

March 2 (Reuters) - Selecta Biosciences Inc  SELB.O :
    * SELECTA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * QTRLY EARNINGS PER SHARE $0.04
    * QTRLY COLLABORATION AND LICENSE REVENUE $16.8 MILLION
VERSUS
$29.9 MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.07, REVENUE VIEW $11.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbTgDfF 
Further company coverage:  SELB.O